IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemia

Haematologica

Volumn 95, Issue 3, 2010, Pages 470-475

  Hunter, Zachary R ^a   Manning, Robert J ^a   Hanzis, Christine ^a   Ciccarelli, Bryan T ^a   Ioakimidis, Leukothea ^a   Patterson, Christopher J ^a   Lewicki, Megan C ^a   Tseng, Hsuiyi ^a   Gong, Ping ^a   Liu, Xia ^a   Zhou, Yangsheng ^a,b   Yang, Guang ^a,b   Sun, Jenny ^a,b   Xu, Lian ^a,b   Sheehy, Patricia ^a   Morra, Massimo ^c   Treon, Steven P ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Correlagen Diagnostics Inc ^*  (United States)

Author keywords

Hypogammaglobulinemia; Serum IgM levels; Waldenstr m's macroglobulinemia

Indexed keywords

BETA 2 MICROGLOBULIN; CD40 ANTIGEN; CD40 LIGAND; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ADULT; AGED; AICDA GENE; ARTICLE; BTK GENE; FEMALE; GENE; GENE SEQUENCE; HUMAN; IMMUNOGLOBULIN A HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN G HYPOGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SCORING SYSTEM; UNG GENE; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGAMMAGLOBULINEMIA; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFECTION; MALE; MIDDLE AGED; RISK FACTORS; WALDENSTROM MACROGLOBULINEMIA;

EID: 77949693595     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.010348     Document Type: Article

References (23)

1. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. Semin Oncol. 2003;30(2):110-5.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999;10(12):1419-32.
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361-92.
4. Treon SP, Hunter ZR, Aggarwal A, Ewen EP, Masota S, Lee C, et al. Characterization of familial Waldenström's macroglobulinemia. Ann Oncol. 2006;17(3):488-94.
5. Stanley PJ, Corbo G, Cole PJ. Serum IgG subclasses in chronic and recurrent respiratory infections. Clin Exp Immunol. 1984;58(3):703-8.
6. Orfao A, Gonzalez M, San Miguel JF, Tomas JF, Canizo MC, Lopez-Berges MC, et al. Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia. Haematologica. 1990;23(1):49-56.
7. Biggar RJ, Christiansen M, Rostgaard K, Smedby KE, Adami HO, Glimelius B, Hjalgrim H, Melbye M. Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer. 2009;124(11):2616-20
8. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37(8):829-34.
9. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199-227.
10. Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol. 2003;4(10):1023-8.
11. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881-90.
12. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37(8):820-8.
13. Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J, et al. International Prognostic Scoring System for Waldenstrom macroglobulinemia. Blood. 2009;113(18):4163-70.
14. Kimby E, Treon SP, Anagnostopoulos A, Dimopoulos M, Garcia-Sanz R, Gertz MA, et al. Update on recommendations for assessing response from the Third International Workshop on Waldenström's Macroglobulinemia. Clin Lymphoma Myeloma. 2006;6(5):380-3.
15. Morra E, Cesana C, Klersy C, Barbano L, Miqueleiz S, Varettoni M, et al. Prognostic factors for transformation in asymptomatic immunoglobulin M monoclonal gammopathies. Clin Lymphoma Myeloma. 2005;5(4):265-9.
16. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton III JL, Rajkumar SV. IgM monoclonal gammopathy for undetermined significance and smoldering Waldenström's macroglobulinemia. Clin Lymphoma Myeloma 2009;9(1):17-8.
17. Raanani P, Gafter-Gvili A, Paul M, Ben-Bassat I, Leibovici L, Shpilberg O. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis. Leuk Lymphoma. 2009;50(5):764-72.
18. Treon SP, Hunter ZR, Matous J, Joyce RM, Mannion B, Advani R, et al. Multicenter clinical trial of bortezomib in relapsed/refractory Waldenström's macroglobulinemia: results of WMCTG trial 03-248. Clin Cancer Res. 2007;13(11): 3320-5.
19. Treon SP. How I treat Waldenstrom's macroglobulinemia. Blood. 2009;114(12):2375-85.
20. Mol CD, Arvai AS, Slupphaug G, Kavli B, Alseth I, Krokan HE, Tainer JA. Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell 1995;80(6):869-78.
21. Sousa MM, Krokan HE, Slupphaug G. DNA-uracil and human pathology. Mol Aspects Med. 2007;28(3-4):276-306.
22. Nilsen H, Stamp G, Andersen S, Hrivnak G, Krokan HE, Lindahl T, Barnes DE. Genetargeted mice lacking the UNG uracil-DNA glycosylase develop B-cell lymphomas. Oncogene. 2003;22(35):5381-6.
23. Andersen S, Ericsson M, Dai HY, Peña-Diaz J, Slupphaug G, Nilsen H, et al. Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase mice. DNA Repair. 2005;4(12):1432-41.